PIB Headquarters
PIB’S BULLETIN ON COVID-19
|
|
- Over 59 Cr. vaccine doses have been administered so far under Nationwide Vaccination Drive
- 25,467 new cases in the last 24 hours
- Active cases account for less than 1% of total cases, currently at 0.98%; lowest since March 2020
- India's Active caseload stands at 3,19,551; lowest in 156 days
- Recovery Rate increases to 97.68%; Highest since March 2020
- 39,486 recoveries in the last 24 hours increases Total Recoveries to 3,17,20,112
- Weekly Positivity Rate  less than 3% for last 60 days
- Daily positivity rate  less than 3% for last 29 days
- 50.93 cr Total Tests conducted so far
#Unite2FightCorona#IndiaFightsCorona
PRESS INFORMATION BUREAU
MINISTRY OF INFORMATION & BROADCASTING
GOVERNMENT OF INDIA
COVID-19 Update
India’s Cumulative COVID-19 Vaccination Coverage exceeds 59 Cr
Recovery Rate  at its highest since March 2020
25,467 New Cases reported in the last 24 hours
At less than 1% of total cases, Active Cases lowest since March 2020
India's Active Caseload  lowest in 156 days is 0.98% of Total Cases
Daily Positivity Rate  less than 3% for last 29 days
India’s COVID-19 vaccination coverage has surpassed the cumulative figure of 59 crores. As per provisional reports till 7 am today, over58.89 Cr  vaccine doses had been administered. This had been achieved through 65,03,493 sessions.
The break-up of the cumulative figure as per the provisional report till 8 am today include:
|
|
HCWs
|
|
1st Dose
|
|
1,03,53,692
|
|
2nd Dose
|
|
82,32,742
|
|
FLWs
|
|
1st Dose
|
|
1,83,07,076
|
|
2nd Dose
|
|
1,26,40,318
|
|
Age Group 18-44 years
|
|
1st Dose
|
|
22,03,32,468
|
|
2nd Dose
|
|
2,03,29,375
|
|
Age Group 45-59 years
|
|
1st Dose
|
|
12,34,70,622
|
|
2nd Dose
|
|
4,93,70,668
|
|
Over 60 years
|
|
1st Dose
|
|
8,36,87,351
|
|
2nd Dose
|
|
1,03,53,692
|
|
Total
|
|
58,89,97,805
The Union Government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country.
The recovery of 39,486 patients in the last 24 hours has increased the cumulative tally of recovered patients  to 3,17,20,112.
Consequently, India’s recovery rate stands at 97.68%, the highest since March 2020.
Sustained and collaborative efforts by the Centre and the States/UTs continue the trend of less than 50,000 Daily New Cases that is being reported for 58 consecutive days now.
25,467 new cases were reported in the last 24 hours.
High recoveries and a low number of new cases have subsided the Active Caseload to 3,19,551 which is at its lowest in 156 days. At 0.98%, Active cases presently form less than 1% of the country's total Positive Cases. Active Caseload is at its lowest since March 2020.
The testing capacity across the country continues to be expanded. The last 24 hours saw a total of 16,47,526 tests being conducted. India has so far conducted over 50.93 Cr  cumulative tests.
While testing capacity has been enhanced across the country, Weekly Positivity Rate at 1.90% remains less than 3% for the last 60 days now. The Daily Positivity rate also stands at 1.55%. The daily Positivity rate has remained below 3% for the last 29 days and below 5% for 78 consecutive days now.
Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1748459
Update on COVID-19 Vaccine Availability in States/UTs
More than 57.15 Crore vaccine doses provided to States/UTs
More than 1 Crore doses in Pipeline
As part of the nationwide vaccination drive, Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In the new phase of the universalization of the COVID19 vaccination drive, the Union Government will procure and supply  75% of the vaccines being produced by the vaccine manufacturers in the country to States and UTs.
|
|
VACCINE DOSES
|
|

|
|
SUPPLIED
|
|
57,15,22,580
|
|
PIPELINE
|
|
1,00,84,700
|
|
BALANCE AVAILABLE
|
|
3,29,58,715
More than 57.15 crore  vaccine doses have been provided to States/UTs so far through Govt of India  and through direct state procurement category. Further, 1,00,84,700 doses are in the pipeline.
More than 3.29 Cr  balance and unutilized COVID Vaccine doses are still available with the States/UTs to be administered.
Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1748473
Vice President urges medical fraternity to educate people on the safety of COVID-19 vaccine to make it a people’s movement
Calls upon people’s representatives to ensure vaccination of people in their constituencies
Vaccination is the most effective shield against COVID-19: VP
VP advises media to dispel false beliefs with accurate information
VP cautions people against complacency, says “we are still not totally out of the woods”
VP urges the private sector to supplement government’s efforts in giving boost to health infrastructure
VP launches ‘Vaccinate India Programme’
The Vice President, Shri M Venkaiah Naidu today urged the medical fraternity in general and the Indian Medical Association, in particular, to take up special awareness campaigns to educate the people about the safety and importance of getting vaccinated against COVID-19.
Inaugurating ‘Vaccinate India Programme’, an initiative of Sustainable Goals Coordination Center, Government of Karnataka in collaboration with Give India Foundation, the Vice President said, there appears to be hesitancy in some quarters to get vaccinated. It is absolutely essential to educate and create awareness among those who are still harboring doubts, he added.
Calling for turning COVID vaccination drive into a ‘Jan-Andolan’, Shri Naidu exhorted all people’s representatives to ensure that everyone is vaccinated in their constituencies. He also urged the media to educate people on the need to shed vaccine hesitancy. “False beliefs need to be dispelled by providing accurate information,” he stressed.
Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1748500
DBT-BIRAC supported Nation’s first mRNA-based vaccine found to be safe gets a nod from the Drugs Controller General of India DCG to move into Phase II/III trial
India’s First COVID-19, mRNA vaccine developed in partnership with DBT-BIRAC under Mission COVID Suraksha
Gennova Biopharmaceuticals Ltd., the Pune-based biotechnology company, working on the nation's first mRNA-based COVID-19 vaccine, submitted the interim clinical data of the Phase I study to the Central Drugs Standard Control Organisation , the Government of India's National Regulatory Authority .
Vaccine Subject Expert Committee  reviewed the interim Phase I data and found that HGCO19 was safe, tolerable, and immunogenic in the participants of the study.
Gennova submitted the proposed Phase II and Phase III study entitled "A Prospective, Multicentre, Randomized, Active-controlled, Observer-blind, Phase II study seamlessly followed by a Phase III study to evaluate the Safety, Tolerability, and Immunogenicity of the candidate HGCO19  in healthy subjects" which was approved by the office of the DCG, CDSCO
Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1748520
Union Health Minister Shri Mansukh Mandaviya inaugurates OPD services in the new AYUSH building and night shelter at AIIMS Deoghar
“New facilities will benefit more than 3 crore population of Jharkhand”: Shri. Mansukh Mandaviya
The Union Health Minister took the occasion to point out that the Union Government under the dynamic leadership of the Prime Minister Shri. Narendra Modi has always stood by the States throughout the Pandemic. The ECRP-1 and ECRP-II  have played a huge role in mounting a sturdy Public Health Response to COVID. Similarly, the Pradhan Mantri Swasthya Suraksha Yojana  is addressing the regional imbalance in tertiary medical care and is providing quality medical education in underserved States.
Shri Mansukh Mandaviya said that centre has helped Jharkhand in every possible way in its fight against COVID-19. He invoked the concept of ‘Antyodaya’ of serving the last citizen in the society as propounded by Shri Deendayal Upadhyaya as the guiding principle of the Union Health Ministry’s efforts to implement PMSSY.
Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1748505
Important Tweets